| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cue Biopharma, Inc. (CUE) has 10 insiders with recent SEC Form 4 filings, including 10 buys and 0 sells. CUE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.88M | $65.63M | - | |
| Other | 125.0K | $4.38M | - | |
| VP | 70.0K | $2.45M | - | |
| Other | 50.0K | $1.75M | - | |
| Dir | 24.4K | $854.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2018 | Marlett Christopher A | Director | Buy | 18,521 | $4.64 | $85,937.44 | +26.1% | |
| Dec 28, 2018 | Digiandomenico Anthony | Director | Buy | 7,000 | $4.62 | $32,340.00 | +14.0% | |
| Dec 27, 2018 | Digiandomenico Anthony | Director | Buy | 20,000 | $4.77 | $95,400.00 | +66.7% | |
| Dec 26, 2018 | Marlett Christopher A | Director | Buy | 19,647 | $4.29 | $84,285.63 | +38.2% | |
| Dec 24, 2018 | Digiandomenico Anthony | Director | Buy | 10,000 | $4.81 | $48,100.00 | +50.0% | |
| Dec 21, 2018 | Suri Anish69 | Chief Scientific Officer | Buy | 2,000 | $4.37 | $8,740.00 | New | |
| Dec 21, 2018 | Marlett Christopher A | Director | Buy | 17,200 | $4.53 | $77,916.00 | +50.2% | |
| Dec 21, 2018 | Digiandomenico Anthony | Director | Buy | 10,000 | $4.49 | $44,900.00 | +100.0% | |
| Dec 20, 2018 | Marlett Christopher A | Director | Buy | 9,438 | $4.74 | $44,736.12 | +38.1% | |
| Dec 19, 2018 | Marlett Christopher A | Director | Buy | 400 | $5.00 | $2,000.00 | +1.6% |